Integrated analysis and network pharmacology approaches to explore key genes of Xingnaojing for treatment of Alzheimer's disease
Abstract Background Alzheimer's disease (AD), as a neurodegenerative condition, is one of the leading causes of dementia. Our study aims to explore the key genes of Xingnaojing (XNJ) for treatment of AD by integrated microarray analysis and network pharmacology. Methods The differentially expre...
Main Authors: | Meixia Wang, Shouyong Wang, Yong Li, Gaomei Cai, Min Cao, Lanfang Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-06-01
|
Series: | Brain and Behavior |
Subjects: | |
Online Access: | https://doi.org/10.1002/brb3.1610 |
Similar Items
-
Alzheimer's disease: some pharmacological and non-pharmacological approaches to correcting neuropsychiatric disorders
by: E. G. Mendelevich
Published: (2018-11-01) -
Network pharmacology used to decode potential active ingredients in Ferula assafoetida and mechanisms for the application to Alzheimer’s disease
by: Meng Xu, et al.
Published: (2020-04-01) -
Systems pharmacology-based approach to investigate the mechanisms of Danggui-Shaoyao-san prescription for treatment of Alzheimer’s disease
by: Qihui Wu, et al.
Published: (2020-09-01) -
Unmet Needs in Pharmacological Treatment of Apathy in Alzheimer’s Disease: A Systematic Review
by: Christos G. Theleritis, et al.
Published: (2019-10-01) -
Xingnaojing ameliorates synaptic plasticity and memory deficits in an Aβ1–42 induced mouse model of Alzheimer's disease
by: Yi Liu, et al.
Published: (2020-08-01)